Molecular Partners AG (MOLN)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
May 16, 16:00
Molecular Partners Accounts Payable (Quarterly): 0.4881M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4881M |
| September 30, 2023 | 2.298M |
| June 30, 2023 | 3.046M |
| March 31, 2023 | 3.130M |
| December 31, 2022 | 1.075M |
| September 30, 2022 | 3.505M |
| June 30, 2022 | 5.814M |
| March 31, 2022 | 4.928M |
| December 31, 2021 | 5.319M |
| September 30, 2021 | 4.064M |
| June 30, 2021 | 11.42M |
| December 31, 2020 | 3.205M |
| June 30, 2020 | 2.421M |
| December 31, 2019 | 2.084M |
| June 30, 2019 | 3.019M |
| Date | Value |
|---|---|
| June 30, 2019 | 3.019M |
| December 31, 2018 | 2.141M |
| June 30, 2018 | 2.293M |
| June 30, 2018 | 2.293M |
| December 31, 2017 | 0.735M |
| June 30, 2017 | 1.598M |
| June 30, 2017 | 1.598M |
| December 31, 2016 | 1.009M |
| June 30, 2016 | 2.802M |
| June 30, 2016 | 2.802M |
| December 31, 2015 | 1.245M |
| June 30, 2015 | 0.9656M |
| June 30, 2015 | 0.9656M |
| December 31, 2014 | 0.3478M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.4881M
Minimum
Dec 2023
11.42M
Maximum
Jun 2021
3.677M
Average
3.088M
Median
Accounts Payable (Quarterly) Benchmarks
| AC Immune SA | 3.144M |
| CRISPR Therapeutics AG | 16.46M |
| Addex Therapeutics Ltd | 1.172M |
| NLS Pharmaceutics Ltd | 3.113M |
| MoonLake Immunotherapeutics | 1.630M |